首页> 外文期刊>International Journal of Research in Medical Sciences >Diagnostic spectrum of CSF involvement by malignant cells: three-year experience of tertiary care hospital in CSF cytology
【24h】

Diagnostic spectrum of CSF involvement by malignant cells: three-year experience of tertiary care hospital in CSF cytology

机译:恶性细胞CSF参与的诊断谱:CSF细胞学中第三节护理医院的三年经验

获取原文
获取外文期刊封面目录资料

摘要

Background: Cerebrospinal fluid (CSF) cytology is the diagnostic gold standard test for primary or metastatic involvement of central nervous system (CNS) by malignancy. It is a very important and routinely done test in the laboratory but its sensitivity is low due to many confounding factors and varies amongst type of malignancies. We did retrospective analysis of CSF cytology carried out at our center from January 2013 to December 2015 to find out about spectrum of malignancies being detected on CSF cytology. Methods: From January 2013 to December 2015, three hundred and seventy-five CSF samples were received and processed for presence of malignant cells at our center. The cytospin preparations stained with LG and PAP stains of these CSF samples were analyzed along with any special stain that was available in the records. Clinical details of the patients with positive cytology were correlated from records. Results: The diagnostic spectrum obtained through study of positive CSF cytology included cases of metastatic solid malignancies and hematolymphoid malignancies. Four cases out of ten were of Metastatic Adenocarcinoma with primary origin being Breast, Lung and Stomach. Out of six cases of hematolymphoid malignancies; five were known cases of lymphoma/leukemia and one was primarily diagnosed to have Non-Hodgkin’s lymphoma (NHL) on CSF cytology. Conclusions: Both Epithelial and Hematolymphoid malignancies can be diagnosed on CSF cytology and these are predominantly metastatic in origin; Hematolymphoid malignancies are more common in CSF than solid malignancies. Correlation with clinical details and Neuroimaging is a must.
机译:背景:脑脊髓液(CSF)细胞学是恶性肿瘤中枢神经系统(CNS)的诊断金标准试验。在实验室中,这是一个非常重要和经常做的测试,但由于许多混淆因素,其敏感性较低,并且在恶性肿瘤的类型中变化。我们在2013年1月到2015年1月至2015年12月在我们的中心进行了对CSF细胞学进行的回顾性分析,以了解CSF细胞学中检测到的恶性肿瘤谱。方法:2013年1月至2015年12月,收到了三百七十五个CSF样品,并在我们中心的恶性细胞存在下加工。通过这些CSF样品的LG和PAP染色染色的细胞螺旋素制剂与记录中可用的任何特殊污渍分析。阳性细胞学患者的临床细节与记录相关。结果:通过研究阳性CSF细胞学研究获得的诊断光谱包括转移性固体恶性肿瘤和血抗体恶性肿瘤病例。十种案例中的四种病例是转移性腺癌,主要是乳腺癌,肺和胃。血淋巴恶性肿瘤的6例;已知淋巴瘤/白血病的已知病例,并且主要被诊断为CSF细胞学对非霍奇金淋巴瘤(NHL)。结论:上皮和血小玉淋巴恶性肿瘤均可诊断出CSF细胞学,这些是原产地的转移性;血管映淋巴恶性肿瘤比固体恶性肿瘤更常见。与临床细节和神经影像元的相关性是必须的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号